| Your Space |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Hair Loss > Hair Loss and Scalp Treatment For Men |
|
Your Space - Hair Loss and Scalp Treatment For Men
For many men, hair
loss can happen at
any time. If this is
happening to you,
you are not alone. For many men, losing hair is so According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product mething will have to be faced as
part of the aging process. If this is
happening to you, you are not alone,
as a simple walk down th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e street will
show you. About 25 per cent of men
begin losing hair before they reach 30
and two thirds before the age of 60.
Somet lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. imes men can begin losing hair
in their teens and can reach their early
twenties with very little, if any, hair left
on the crown of here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe their head. Usually,
however, the hair loss is gradual,
developing over a period of twenty to
thirty years. The most common cause d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro of hair loss
in men is genetic: Androgenetic alopecia (male pattern baldness) has a characteristic pattern of hair loss; it begins ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc with a slight
recession at the front hairline and is
followed by thinning on the crown of
the head. The hair above the ears and
at easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the nape of the neck is unaffected.
This hair loss results from a complex
chemical reaction when the enzyme 5alpha-reductase converts nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the
testosterone in the system into DHT or
dihydrotestosterone. The hair follicles
are genetically predisposed to be
oversensitive and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to the DHT and become
smaller and smaller with time, leading
to the eventual hair loss. If you are suffering from patchy hair loss ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi you may be suffering from
another form of alopecia: Alopecia areata is an extremely common condition and will affect 1% to 2% of t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a he population at some
point in their lives. Most sufferers are
children and young adults (below 40
years old), though it can affect dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod people of all ages. The hair loss is sudden and
manifests itself in small, smooth-
skinned patches that are likely to
gradually widen cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin with time. It can also
affect the sufferer’s nails, giving them
a pitted, ridged or brittle appearance.
The exact cause is still un tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nown,
although current theories include an
auto-immune disease, stress or
suggest a genetic basis. If the hair loss
progresses unt t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel il all the scalp hair is lost
this is known as alopecia totalis or
alopecia universalis if all the body
hair is lost as well. Hair ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust loss can also result from a scalp
problem. Inflammation of the scalp
leads to production of superoxide,
which causes hair shedding a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd will
lead to diffuse hair loss. These are just a few of the reasons for hair loss. It order to treat hair loss effectively we wo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de uld recommend that
you have a diagnosis made as soon as
possible by one of our experienced
trichologists. Stress can be an
aggrava elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tor in almost all cases of hair
loss and an accurate diagnosis will
always, at the very least, take some of
the stress away from you tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:FTA (Free to Air) Receivers & Files VoIP and Your Broadband Selection
|